de Vries, C R
Monken, C E
Lattime, E C
Article History
Received: 10 December 2014
Revised: 30 December 2014
Accepted: 30 December 2014
First Online: 30 January 2015
Competing interests
: Dr Lattime is an inventor of the patented recombinant Vaccinia-GMCSF that has been licensed to Sillajen and is being studied as JX-594. As such, he derives royalties and licensing fees from the Thomas Jefferson University where the patent is held. The remaining authors declare no conflict of interest.
Free to read: This content has been made available to all.